Wave Life Sciences Ltd. - Ordinary Shares (WVE): Price and Financial Metrics
Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Today's Latest Price: $7.07 USD
Updated Oct 30 4:00pm
Add WVE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
WVE Stock Summary
- Wave Life Sciences Ltd's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 3.52% of US listed stocks.
- WVE's price/sales ratio is 20.59; that's higher than the P/S ratio of 92.72% of US stocks.
- As for revenue growth, note that WVE's revenue has grown -33.3% over the past 12 months; that beats the revenue growth of just 7.78% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Wave Life Sciences Ltd are VBLT, SYBX, KALV, NTLA, and FIXX.
- Visit WVE's SEC page to see the company's official filings. To visit the company's web site, go to www.wavelifesciences.com.
WVE Stock Price Chart Interactive Chart >
WVE Price/Volume Stats
| Current price | $7.07 | 52-week high | $39.98 |
| Prev. close | $7.30 | 52-week low | $6.61 |
| Day low | $6.76 | Volume | 1,074,900 |
| Day high | $7.44 | Avg. volume | 769,855 |
| 50-day MA | $10.81 | Dividend yield | N/A |
| 200-day MA | $9.58 | Market Cap | 257.73M |
Wave Life Sciences Ltd. - Ordinary Shares (WVE) Company Bio
WAVE Life Sciences Pte. Ltd., a preclinical biopharmaceutical company, designs, develops, and commercializes nucleic acid therapeutic candidates. The company was founded in 2012 and is based in Simgapore.
Loading social stream, please wait...